AbstractIntroduction: Most diseases of the breast present as a palpable mass. the accuracy of identification are often accrued by a mixture of surgical tests like physical examination, diagnostic procedure, fine-needle aspiration cytology (FNAC), and Trucut needle biopsy (TGNB) or core needle biopsy (CNB). FNAC has big in quality and have become the primary initial used procedure when history taking and clinical examination for identification of solid and cystic breast lumps. Methods: Total period three years of FNAC and Trucut biopsy and were compared with tissue identification. Variables like age, legal status, duration, size, expelling standing and web site were analyzed using applied math
analysis. Results: In our study of eighty patients presenting to our institute throughout such as amount with clinical suspicion of malignant neoplastic disease breast, the sensitivity, specificity, positive prognostic price and also the negative prognostic price of FNAC in diagnosing the carcinoma is eighty five. 7%, 100%, 100% & 21.4% severally. The sensitivity, specificity, positive prognostic price and also the negative prognostic price of true cut diagnostic assay in designation the carcinoma is 89.6%, 100%, 100% & 27.3%. There have been seventy nine (98.75%) females and one (1.25%) males within the study. Within the study, axillary lymphoid tissue involvement is 57.5%. Majority thirty two (40%) of the patients had bestowed with lump within the higher outer quadrant of the breast. Conclusions: Results of our study demonstrated FNAC & Tru-cut assay were useful in confirmation of identification with diagnostic accuracy of Tru-cut being over FNAC. Most patients with malignant neoplastic disease breast underwent MRM with post operative chemoradiotherapy with advanced stages requiring neoadjuvant medical aid.
Keywords: Breast lump; FNAC; Mammography; Malignancy; Trucut biopsy; Tissue diagnosis.